EOLS Cash from Investing Activities - Cash Flow Statement - Evolus, Inc. - IntrinsicAlpha

Evolus, Inc. EOLS

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

$ 14.49

1.97 %

$ 918 M

Market Cap

-15.92

P/E

EOLS - CASH FROM INVESTING ACTIVITIES

Cash from Investing Activities EOLS - Evolus, Inc.

-1.63 M

LAST VALUE

-18.48%

2 YEAR CAGR

-182.77%

5 YEAR CAGR

0.00%

10 YEAR CAGR